Samaritan Pharmaceuticals, Inc. Licenses Exclusive Rights to Infectious Disease Compounds From Georgetown University

LAS VEGAS, July 24, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, announced today that it has entered into an exclusive license agreement with Georgetown University for “Benzamide Compounds” patent rights to treat HIV and numerous other infectious diseases.

MORE ON THIS TOPIC